tiprankstipranks
NewGen BioPharma Corp. (NEWG)
OTHER OTC:NEWG
US Market

NewGen BioPharma (NEWG) Financial Statements

4 Followers

NewGen BioPharma Financial Overview

NewGen BioPharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; NewGen BioPharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jan 17Oct 16Jul 16Apr 16Jan 16
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit----$ 0.00
EBIT$ -154.83K$ -20.54K$ -4.00K$ -6.04K$ -11.29K
EBITDA$ -154.83K$ -20.54K$ -4.00K$ -6.04K$ -11.29K
Net Income Common Stockholders$ -153.47K$ -20.54K$ -4.00K$ -6.04K$ -11.29K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 201.36K$ 0.00$ 0.00$ 0.00$ 0.00
Total Debt$ 0.00$ 94.38K$ 0.00$ 0.00$ 0.00
Net Debt$ 0.00$ 94.38K$ 0.00$ 0.00$ 0.00
Total Liabilities$ 230.00K$ 125.18K$ 104.64K$ 100.64K$ 94.59K
Stockholders Equity$ -28.65K$ -125.18K$ -104.64K$ -100.64K$ -94.59K
Cash Flow-
Free Cash Flow$ -11.08K$ -6.30K$ 0.00$ -7.85K$ -10.58K
Operating Cash Flow$ -11.08K$ -6.30K$ 0.00$ -7.85K$ -10.58K
Investing Cash Flow$ 0.00---$ 0.00
Financing Cash Flow$ 11.08K$ 6.30K$ 0.00$ 7.85K$ 10.58K
Currency in USD

NewGen BioPharma Earnings and Revenue History

NewGen BioPharma Debt to Assets

NewGen BioPharma Cash Flow

NewGen BioPharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis